Pharmabiz1d
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...
Toronto Life1d
Compassionate care for Toronto’s most vulnerable
The first thing that often comes to mind when we think of a hospital emergency room (ER ... that don’t fit the classic notion ...
Loughborough University3d
School of Sport, Exercise and Health Sciences
As the No.1 University in the world for sport-related subjects, we offer unrivalled research, teaching and partnerships across sport, exercise and health sciences. Our expertise spans the fields of ...